Sands Capital Management 13F holdings, Q1 2009
Holdings as of March 31, 2009 · filings on SEC EDGAR · latest filing →
Sands Capital Management disclosed 40 US equity positions worth $8.1bn in its Q1 2009 13F filing. The largest position was GOOGLE at 8.0% of the reported book, followed by AAPL and ALLERGAN. Against the Q4 2008 filing, it opened 7 new positions, added to 21 and reduced 12 among the top 40 holdings.
What did Sands Capital Management own in Q1 2009? Top 40 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2008 |
|---|---|---|---|---|---|---|---|
| 1 | 8.0% | $651.8m | 1,872,753 | – | new | ||
| 2 | AAPL APPLE | Technology | 7.9% | $645.9m | 6,144,567 | 2% | added |
| 3 | ALLERGAN | 7.3% | $598.4m | 12,529,691 | -1% | reduced | |
| 4 | AMZN AMAZON.COM | Consumer Cyclical | 7.2% | $585.1m | 7,967,235 | – | new |
| 5 | NATIONAL OILWELL VARCO | 6.9% | $559.2m | 19,475,863 | 7% | added | |
| 6 | GENZYME | 6.1% | $497.2m | 8,372,483 | 1% | added | |
| 7 | V VISA INC | Financial Services | 6.0% | $491.7m | 8,843,918 | 5% | added |
| 8 | INTERCONTINENTAL EXCHANGE | 5.7% | $466.4m | 6,262,897 | 2% | added | |
| 9 | SLB SCHLUMBERGER | Energy | 4.6% | $377.6m | 9,296,075 | 4% | added |
| 10 | FMC TECHNOLOGIES | 3.6% | $297.0m | 9,466,717 | 10% | added | |
| 11 | QCOM QUALCOMM | Technology | 3.6% | $291.3m | 7,487,555 | 11% | added |
| 12 | AVGO BROADCOM | Technology | 3.6% | $290.1m | 14,517,029 | 1% | added |
| 13 | MONSANTO | 3.4% | $277.4m | 3,337,922 | 5% | added | |
| 14 | CRM SALESFORCE.COM | Technology | 3.4% | $277.0m | 8,462,209 | 7% | added |
| 15 | CME CME GROUP | Financial Services | 3.2% | $258.9m | 1,050,854 | -2% | reduced |
| 16 | EMC CORP | 3.1% | $250.8m | 22,003,455 | -4% | reduced | |
| 17 | AMERICA MOVIL SPON | 2.8% | $230.0m | 8,494,189 | 4% | added | |
| 18 | VARIAN MEDICAL SYSTEMS | 2.8% | $227.1m | 7,459,847 | – | new | |
| 19 | SYK STRYKER | Healthcare | 2.1% | $171.7m | 5,042,717 | -3% | reduced |
| 20 | MINDRAY MEDICAL INTL SPON | 1.9% | $156.6m | 8,460,533 | 12% | added | |
| 21 | MCO MOODYS CORP | Financial Services | 1.8% | $148.5m | 6,478,316 | -7% | reduced |
| 22 | IRON MOUNTAIN | 1.6% | $129.5m | 5,841,758 | -3% | reduced | |
| 23 | LVS LAS VEGAS SANDS | Consumer Cyclical | 1.6% | $127.8m | 42,446,692 | 12% | added |
| 24 | ABRAXIS BIOSCIENCE | 0.6% | $50.0m | 1,048,112 | -6% | reduced | |
| 25 | ALCON | 0.3% | $21.2m | 232,725 | 963% | added | |
| 26 | ABBNY ABB LTD | Industrials | 0.2% | $14.0m | 1,004,150 | – | new |
| 27 | ASML | 0.1% | $11.4m | 649,300 | – | new | |
| 28 | MELI MERCADOLIBRE | Consumer Cyclical | 0.1% | $9.4m | 504,500 | – | new |
| 29 | NUVASIVE | 0.1% | $7.7m | 244,575 | -11% | reduced | |
| 30 | CELG CELGENE | 0.0% | $4.0m | 91,100 | 3% | added | |
| 31 | ST. JUDE MEDICAL | 0.0% | $3.6m | 99,800 | 38% | added | |
| 32 | GILD GILEAD SCIENCES | Healthcare | 0.0% | $3.4m | 73,900 | 46% | added |
| 33 | GHDX GENOMIC HEALTHCARE INC | 0.0% | $3.3m | 136,400 | – | new | |
| 34 | BMRN BIOMARIN PHARMS | Healthcare | 0.0% | $3.0m | 241,300 | -10% | reduced |
| 35 | VRTX VERTEX PHARMS | Healthcare | 0.0% | $2.3m | 79,800 | -14% | reduced |
| 36 | ALNY ALNYLAM PHARMS | Healthcare | 0.0% | $2.3m | 118,600 | 3% | added |
| 37 | HANSEN MEDICAL | 0.0% | $1.5m | 374,533 | 4% | added | |
| 38 | MEDAREX | 0.0% | $1.2m | 237,700 | 4% | added | |
| 39 | SEQUENOM INC | 0.0% | $904.0k | 63,600 | -60% | reduced | |
| 40 | CSCO CISCO SYSTEMS | Technology | 0.0% | $268.0k | 16,000 | -83% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.